Enhancing Screening Practices for BE

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRutgers, The State University of New Jersey

About this trial

Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients with risk factors. The purpose of this study is to examine current screening practices and determine if implementation of screening reminders can optimize screening practices for Barrett's Esophagus within a large, academic based healthcare system in NJ.

Eligibility criteria

Qualifiers

18 years of age or older

Have a scheduled appointment with a participating provider

Disqualifiers

Less than 18 years of age

Trial design

Treatments tested in this trial

  • Screening Reminder

Treatment groups

3,000 Participants
are divided into 2 treatment groups